Browse Studies — Arctuva

Phase 2

A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation

The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), doubl…

Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more

Estimated

~$10 – $7,500

Paul SzabolcsNCT01962415

Phase 3

Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis

This study aims to evaluate the efficacy of cefixime compared to benzathine penicillin G in the treatment of syphilis.

SyphilisHuman Immunodeficiency Virus

Estimated

~$10 – $6,250

University of Southern CaliforniaNCT04958122

The Prospective Collection, Storage and Reporting of Data on Patients

To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematop…

Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more

Estimated

~$10 – $750

Wake Forest University Health SciencesNCT01890486

Observational

Evaluation of a Persuasive Health Communication Intervention Designed to Increase HIV/HCV Screening Among Emergency Departments Patients Who Currently, Formerly or Never Injected Drugs.

A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV dec…

Human Immunodeficiency Virus (HIV)Hepatitis C (HCV)

Estimated

~$10 – $6,250

University of South FloridaNCT05968573